The Ozempic Customer: How GLP-1 Is Feeding the Non-Alcoholic Boom
Gilles Miller
Industry Insider, Upside Drinks
People on GLP-1 drugs keep reporting the same quiet, strange thing. The second glass of wine stopped being interesting. Not forbidden, not white-knuckled. Just gone, the way a song you used to love can one day sound like nothing.
No resolution. No Dry January. They started a weekly shot, Ozempic, Wegovy, Mounjaro, for their weight or their blood sugar, and somewhere around week three the craving for alcohol slipped out the back door on its own.
There are a lot of them now, and the non-alcoholic category is being handed a customer it never had to convince.
THE NUMBERS ARE REAL
- Roughly 1 in 8 US adults now takes a GLP-1 drug, and nearly 1 in 5 has tried one (KFF, 2025)
- Among those who drank, 44% reported drinking less within three months of starting, against 53% no change and 3% more (JAMA Psychiatry, 2026)
- In a controlled trial, semaglutide cut both alcohol craving and drinks per drinking session (JAMA Psychiatry, 2025)
- Wine feels it most: in one industry consumer survey, 52% of those cutting back drank less wine, ahead of beer and spirits (EY-Parthenon, 2025)
Translation: a drug taken for weight and blood sugar is quietly turning millions of people into lighter drinkers, with no resolution, no movement, and no marketing behind it.
THEY STILL WANT THE GLASS
Here is the part worth sitting with. These people did not quit drinking. They lost the urge, not the ritual. They still want the cold one at five, the pour at dinner, the glass in their hand while everyone else holds one. The appetite that left was for the alcohol. The appetite for the moment never moved.
That gap is the whole business. Not willpower, not abstinence. A real drink for someone whose body quietly changed its mind about alcohol, and nothing else. It is the second wave argument, with a few million new names on it.
THE PITCH THAT NO LONGER FITS
Most non-alcoholic marketing still speaks the language of discipline: the challenge, the streak, the proof you can go without. It was built for the person talking themselves out of a drink. The Ozempic customer is not talking themselves out of anything, so a message about restraint describes a struggle they no longer have.
The line that fits them is the one the best drinks could always stand on, and it is a kinder one: this is good, and you will not miss what is not in it.
THE VERDICT
The next wave of moderation is not a movement. It is a prescription, and it is writing itself across millions of fridges with no campaign behind it. The brands that grow with it will stop selling the fight against alcohol, and start pouring for the people who were never fighting at all.

Discover our Shop with
1100+ alcohol-free options
From sparkling wines to craft beers and botanical spirits, there's something for everyone.
BROWSE THE STOREYou May Also Like
IndustryWhy Bitter Tastes Different to You
IndustryThe Berry That Makes a Lemon Taste Like Candy
IndustryYou Taste With Your Eyes First
Leave a comment
Please note, comments must be approved before they are published
This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.



